Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Detention and Banned Medical Devices, 63764-63765 [E6-18190]
Download as PDF
63764
Federal Register / Vol. 71, No. 210 / Tuesday, October 31, 2006 / Notices
five minutes per speaker or
organization. As a courtesy, please
inform Ms. Diane Gianelli, Director of
Communications in advance of your
intention to make a public statement,
and give your name and affiliation. To
submit a written statement, mail or
e-mail to Ms. Gianelli at one of the
address given below.
FOR FURTHER INFORMATION CONTACT: Ms.
Diane Gianelli, Director of
Communications, The President’s
Council on Bioethics, Suite 700, 1801
Pennsylvania Avenue, NW.,
Washington, DC 20006. Telephone: 202/
296–4669. E-mail: info@bioethics.gov.
Web site: https://www.bioethics.gov.
Dated: October 16, 2006.
F. Daniel Davis,
PhD., Executive Director, The President’s
Council on Bioethics.
[FR Doc. 06–8968 Filed 10–30–06; 8:45 am]
BILLING CODE 4154–07–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the President’s Council on
Physical Fitness and Sports
Office of Public Health and
Science, Office of the Secretary, DHHS.
ACTION: Notice.
cprice-sewell on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (DHHS) is hereby giving notice
that the President’s Council on Physical
Fitness and Sports will hold a meeting.
This meeting is open to the public. A
description of the Council’s functions is
included with this notice.
DATES: November 15, 2006, from 8:30
a.m. to 4 p.m.
ADDRESSES: Department of Health and
Human Services, Hubert H. Humphrey
Building, Room 800, 200 Independence
Avenue, SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
Melissa Johnson, Executive Director,
President’s Council on Physical Fitness
and Sports, Hubert H. Humphrey
Building, Room 738H, 200
Independence Avenue, SW.,
Washington, DC 20201, (202) 690–5187.
SUPPLEMENTARY INFORMATION: The
President’s Council on Physical Fitness
and Sports (PCPFS) was established
originally by Executive Order 10673,
dated July 16, 1956. PCPFS was
established by President Eisenhower
after published reports indicated that
American boys and girls were unfit
compared to the children of Western
Europe. The Council has undergone two
name changes and several
VerDate Aug<31>2005
15:25 Oct 30, 2006
Jkt 211001
reorganizations since its inception.
Authorization to continue Council
operations has been given at appropriate
intervals by subsequent Executive
Orders. Authority to continue Council
operations was most recently directed
by Executive Order 13385, dated
September 29, 2005. Presently, the
PCPFS serves as a program office that is
located organizationally in the Office of
Public Health and Science within the
Office of the Secretary in the U.S.
Department of Health and Human
Services.
On June 6, 2002, President Bush
signed Executive Order 13256 to
reestablish the PCPFS. Executive Order
13256 was established to expand the
focus of the Council. This directive
instructed the Secretary to develop and
coordinate a national program to
enhance physical activity and sports
participation. The Council currently
operates under the stipulations of the
new directive. The primary functions of
the Council include to: (1) Advise the
President, through the Secretary, on the
progress made in carrying out the
provisions of the enacted directive and
recommend actions to accelerate
progress; (2) advise the Secretary on
ways and means to enhance
opportunities for participation in
physical fitness and sports, and, where
possible, to promote and assist in the
facilitation and/or implementation of
such measures; (3) to advise the
Secretary regarding opportunities to
extend and improve physical activity/
fitness and sports programs and services
at the national, State and local levels;
and (4) to monitor the need for the
enhancement of programs and
educational and promotional materials
sponsored, overseen, or disseminated by
the Council, and advise the Secretary, as
necessary, concerning such needs.
The PCPFS holds at a minimum, one
meeting in the calendar year to (1)
assess ongoing Council activities and (2)
discuss and plan future projects and
programs.
Public attendance at the meeting is
limited to space available. Individuals
must provide a photo ID for entry into
the meeting. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the designated contact person.
Dated: October 25, 2006.
Melissa Johnson,
Executive Director, President’s Council on
Physical Fitness and Sports.
[FR Doc. E6–18244 Filed 10–30–06; 8:45 am]
BILLING CODE 4150–35–P
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N–0220]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Administrative
Detention and Banned Medical Devices
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by November
30, 2006.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
1472.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Administrative Detention and Banned
Medical Devices—(OMB Control
Number 0910–0114)—Extension
FDA has the statutory authority under
section 304(g) of the Federal Food, Drug,
and Cosmetic Act (the act) (21 U.S.C.
334(g)), where officers or employees
(FDA investigators), duly designated by
the Secretary of Health and Human
Services, may detain during
establishment inspections devices that
are believed to be adulterated or
misbranded. In the Federal Register of
March 9, 1979 (44 FR 13234), FDA
issued, under § 800.55 (21 CFR 800.55),
a final regulation on administrative
detention procedures, under section
304(g) of the act, which includes certain
reporting requirements (§ 800.55(g)(1)
and (g)(2)) and recordkeeping
requirements (§ 800.55(k)). Under
§ 800.55(g), an appellant of a detention
order must show documentation of
E:\FR\FM\31OCN1.SGM
31OCN1
63765
Federal Register / Vol. 71, No. 210 / Tuesday, October 31, 2006 / Notices
ownership if devices are detained at a
place other than that of the appellant.
Under § 800.55(k), the owner or other
responsible person must supply records
about how the devices may have
become adulterated or misbranded, as
well as records of distribution of the
detained devices. These recordkeeping
requirements for administrative
detentions allow FDA to trace devices
for which the detention period expired
before a seizure is accomplished or
injunctive relief is obtained.
FDA also has the statutory authority
under section 516 of the act (21 U.S.C.
360f), to ban devices that present
substantial deception, or unreasonable
and substantial risk of illness or injury,
or unreasonable, direct, and substantial
danger to the health of individuals. The
final regulation for banned devices (part
895 (21 CFR part 895)), issued in the
Federal Register of May 18, 1979 (44 FR
29214), contained certain reporting
requirements (§§ 895.21(d) and
895.22(a)).
In the Federal Register of June 7, 2006
(71 FR 32987), FDA published a 60-day
notice requesting public comments on
the information collection provisions.
No comments were received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
No. of
Respondents
21 CFR Section
Annual Frequency
per Response
800.55(g)
Total Annual
Responses
Hours per
Response
Total Hours
1
1
25
25
26
895.21(d) and 895.22(a)
1
1
26
16
416
Total
441
1There
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
No. of
Recordkeepers
21 CFR Section
800.55(k)
1There
1
Dated: October 24, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–18190 Filed 10–30–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N–0426]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Medical Device
User Fee and Modernization Act Small
Business Qualification Certification
(Form FDA 3602)
AGENCY:
Food and Drug Administration,
HHS.
cprice-sewell on PROD1PC66 with NOTICES
Total Annual
Records
1
Hours per
Record
1
Total Hours
20
20
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA’s estimate of the burden under
the administrative detention provision
is based on FDA’s discussion with the
last firm whose devices had been
detained. Historically, FDA has had
very few or no annual responses for this
information collection.
ACTION:
Annual Frequency
per Recordkeeper
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
VerDate Aug<31>2005
15:25 Oct 30, 2006
Jkt 211001
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the proposed collection of information
that will permit an applicant to certify
that it qualifies as a ‘‘small business’’
within the meaning of the Medical
Device User Fee and Modernization Act
(MDUFMA).
DATES: Submit written or electronic
comments on the collection of
information by January 2, 2007.
ADDRESSES: Submit electronic
comments on the collection of
information to: https://www.fda.gov/
dockets/ecomments. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
1472.
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
SUPPLEMENTARY INFORMATION:
E:\FR\FM\31OCN1.SGM
31OCN1
Agencies
[Federal Register Volume 71, Number 210 (Tuesday, October 31, 2006)]
[Notices]
[Pages 63764-63765]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-18190]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N-0220]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Administrative
Detention and Banned Medical Devices
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by
November 30, 2006.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-6974.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of the Chief
Information Officer (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-1472.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Administrative Detention and Banned Medical Devices--(OMB Control
Number 0910-0114)--Extension
FDA has the statutory authority under section 304(g) of the Federal
Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 334(g)), where
officers or employees (FDA investigators), duly designated by the
Secretary of Health and Human Services, may detain during establishment
inspections devices that are believed to be adulterated or misbranded.
In the Federal Register of March 9, 1979 (44 FR 13234), FDA issued,
under Sec. 800.55 (21 CFR 800.55), a final regulation on
administrative detention procedures, under section 304(g) of the act,
which includes certain reporting requirements (Sec. 800.55(g)(1) and
(g)(2)) and recordkeeping requirements (Sec. 800.55(k)). Under Sec.
800.55(g), an appellant of a detention order must show documentation of
[[Page 63765]]
ownership if devices are detained at a place other than that of the
appellant. Under Sec. 800.55(k), the owner or other responsible person
must supply records about how the devices may have become adulterated
or misbranded, as well as records of distribution of the detained
devices. These recordkeeping requirements for administrative detentions
allow FDA to trace devices for which the detention period expired
before a seizure is accomplished or injunctive relief is obtained.
FDA also has the statutory authority under section 516 of the act
(21 U.S.C. 360f), to ban devices that present substantial deception, or
unreasonable and substantial risk of illness or injury, or
unreasonable, direct, and substantial danger to the health of
individuals. The final regulation for banned devices (part 895 (21 CFR
part 895)), issued in the Federal Register of May 18, 1979 (44 FR
29214), contained certain reporting requirements (Sec. Sec. 895.21(d)
and 895.22(a)).
In the Federal Register of June 7, 2006 (71 FR 32987), FDA
published a 60-day notice requesting public comments on the information
collection provisions. No comments were received.
FDA estimates the burden of this collection of information as
follows:
Table 1.--Estimated Annual Reporting Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual Hours per
21 CFR Section Respondents per Response Responses Response Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
800.55(g) 1 1 1 25 25
--------------------------------------------------------------------------------------------------------------------------------------------------------
895.21(d) and 895.22(a) 26 1 26 16 416
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total 441
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 2.--Estimated Annual Recordkeeping Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual
21 CFR Section Recordkeepers per Recordkeeper Records Hours per Record Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
800.55(k) 1 1 1 20 20
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA's estimate of the burden under the administrative detention
provision is based on FDA's discussion with the last firm whose devices
had been detained. Historically, FDA has had very few or no annual
responses for this information collection.
Dated: October 24, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-18190 Filed 10-30-06; 8:45 am]
BILLING CODE 4160-01-S